A COVID-19 vaccine is set to be put forward for emergency approval in the U.S. in a few weeks.
Its developers, Pfizer and BioNTech, said the vaccine could prevent nine out of 10 people from getting COVID-19.
Phase 3 clinical trials still need to be completed and it might take a while to get approval.
But as Emanuela Campanella reports, there’s the potential for a major logistical challenge ahead of us that we need to prepare for: keeping the vaccine at an ultra-cold minus-80 degree.
For more info, please go to https://globalnews.ca/news/7450985/pfizer-coronavirus-vaccine-trials-caution-experts/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews #pfizervaccine
Its developers, Pfizer and BioNTech, said the vaccine could prevent nine out of 10 people from getting COVID-19.
Phase 3 clinical trials still need to be completed and it might take a while to get approval.
But as Emanuela Campanella reports, there’s the potential for a major logistical challenge ahead of us that we need to prepare for: keeping the vaccine at an ultra-cold minus-80 degree.
For more info, please go to https://globalnews.ca/news/7450985/pfizer-coronavirus-vaccine-trials-caution-experts/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews #pfizervaccine
Sign in or sign up to post comments.
Be the first to comment